1 Kalender W A. X-ray computed tomography. Phys Med Biol, 2006, 51: 29-43
[2]
2 Pan X, Siewerdsen J, La Riviere P J, et al. Development of X-ray computed tomography: The role of medical physics and AAPM from the 1970s to present. Med Phys, 2008, 35: 3728-3739
[3]
84 Wang L, Xing H, Zhang S, et al. A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery. Biomaterials, 2013, 34: 3390-3401
[4]
85 Chen F, Huang P, Zhu Y J, et al. The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods. Biomaterials, 2011, 32: 9031-9039
[5]
86 Wu S, Han G, Milliron D J, et al. Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals. Proc Natl Acad Sci USA, 2009, 106: 10917-10921
[6]
87 Liu Z, Li Z, Liu J, et al. Long-circulating Er3+-doped Yb2O3 up-conversion nanoparticle as an in vivo X-ray CT imaging contrast agent. Biomaterials, 2012, 33: 6748-6757
[7]
88 Xing H, Bu W, Zhang S, et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials, 2012, 33: 1079-1089
[8]
89 Zhou J, Zhu X, Chen M, et al. Water-stable NaLuF4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging. Biomaterials, 2012, 33: 6201-6210
[9]
90 Xia A, Chen M, Gao Y, et al. Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-ray computed tomography and magnetic resonance. Biomaterials, 2012, 33: 5394-5405
[10]
91 Zhu X, Zhou J, Chen M, et al. Core-shell Fe3O4@NaLuF4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials, 2012, 33: 4618-4627
[11]
92 Xing H, Bu W, Ren Q, et al. A NaYbF4:Tm3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials, 2012, 33: 5384-5393
[12]
93 Liu Y, Ai K, Liu J, et al. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew Chem Int Ed, 2012, 51: 1437-1442
[13]
94 Ma J, Huang P, He M, et al. Folic acid-conjugated LaF3:Yb, Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography. J Phys Chem B, 2012, 116: 14062-14070
[14]
95 Zeng S, Tsang M K, Chan C F, et al. PEG modified BaGdF5:Yb/Er nanoprobes for multi-modal upconversion fluorescent, in vivo X-ray computed tomography and biomagnetic imaging. Biomaterials, 2012, 33: 9232-9238
[15]
96 Shen J W, Yang C X, Dong L X, et al. Incorporation of computed tomography and magnetic resonance imaging function into NaYF4: Yb/Tm upconversion nanoparticles for in vivo trimodal bioimaging. Anal Chem, 2013, 85: 12166-12172
[16]
97 Ai K, Liu Y, Liu J, et al. Large-scale synthesis of Bi2S3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv Mater, 2011, 23: 4886-4891
[17]
98 Kinsella J M, Jimenez R E, Karmali P P, et al. X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Ed, 2011, 50: 12308-12311
[18]
99 Chen J, Yang X Q, Meng Y Z, et al. In vitro and in vivo CT imaging using bismuth sulfide modified with a highly biocompatible Pluronic F127. Nanotechnology, 2014, 25: 295103
[19]
100 Perera V S, Hao J, Gao M, et al. Nanoparticles of the novel coordination polymer KBi(H2O)2(Fe(CN)6)·H2O as a potential contrast agent for computed tomography. Inorg Chem, 2011, 50: 7910-7912
[20]
101 Pan D, Williams T A, Senpan A, et al. Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. J Am Chem Soc, 2009, 131: 15522-15527
[21]
3 Wathen C A, Foje N, Avermaete T, et al. In vivo X-ray computed tomographic imaging of soft tissue with native, intravenous, or oral contrast. Sensors, 2013, 13: 6957-6980
[22]
4 Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol, 2008, 36: 69-74
[23]
5 Lusic H, Grinstaff M W. X-ray-computed tomography contrast agents. Chem Rev, 2012, 113: 1641-1666
[24]
6 van Herck J L, De Meyer G R Y, Martinet W, et al. Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Basic Res Cardiol, 2010, 105: 51-59
[25]
7 Aillon K L, El-Gendy N, Dennis C, et al. Iodinated nanoclusters as an inhaled computed tomography contrast agent for lung visualization. Mol Pharm, 2010, 7: 1274-1282
[26]
8 Lee N, Choi S H, Hyeon T. Nano-sized CT contrast agents. Adv Mater, 2013, 25: 2641-2660
[27]
9 Idée J M, Guiu B. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review. Crit Rev Oncol Hematol, 2013, 88: 530-549
[28]
10 Jeong J M, Kim Y J, Lee Y S, et al. Lipiodol solution of a lipophilic agent, 188Re-TDD, for the treatment of liver cancer. Nucl Med Biol, 2001, 28: 197-204
[29]
11 Ho Kong W, Jae Lee W, Yun Cui Z, et al. Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging. Biomaterials, 2007, 28: 5555-5561
[30]
12 Li X, Anton N, Zuber G, et al. Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical X-ray imaging. Biomaterials, 2013, 34: 481-491
[31]
13 Trubetskoy V S. Polymeric micelles as carriers of diagnostic agents. Adv Drug Deliver Rev, 1999, 37: 81-88
[32]
14 Galperin A, Margel D, Baniel J, et al. Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications. Biomaterials, 2007, 28: 4461-4468
16 Jacobsen P B, Larsen ？, Konarboland R, et al. Biotransformation of nonionic X-ray contrast agents in vivo and in vitro. Drug Metab Dispos, 1999, 27: 1205-1213
[35]
17 Badea C T, Athreya K K, Espinosa G, et al. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One, 2012, 7: e34496
[36]
18 Samei E, Saunders R S, Badea C T, et al. Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomed, 2009, 4: 277-282
[37]
19 Zheng J, Liu J, Dunne M, et al. In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications. Pharm Res, 2007, 24: 1193-1201
[38]
20 Karathanasis E, Chan L, Balusu S R, et al. Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials, 2008, 29: 4815-4822
[39]
21 Kweon S, Lee H J, Hyung W J, et al. Liposomes coloaded with iopamidol/lipiodol as a RES-targeted contrast agent for computed tomography imaging. Pharm Res, 2010, 27: 1408-1415
[40]
22 Elrod D B, Partha R, Danila D, et al. An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid. Nanomedicine, 2009, 5: 42-45
[41]
23 Wyss C, Schaefer S C, Juillerat-Jeanneret L, et al. Molecular imaging by micro-CT: Specific E-selectin imaging. Eur Radiol, 2009, 19: 2487-2494
[42]
24 Dunne M, Zheng J, Rosenblat J, et al. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. J Control Release, 2011, 154: 298-305
[43]
25 Yordanov A T, Lodder A L, Woller E K, et al. Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging. Nano Lett, 2002, 2: 595-599
[44]
26 Fu Y, Nitecki D E, Maltby D, et al. Dendritic iodinated contrast agents with PEG-cores for CT imaging: Synthesis and preliminary characterization. Bioconjug Chem, 2006, 17: 1043-1056
[45]
27 Yin Q, Yap F Y, Yin L, et al. Poly(iohexol) nanoparticles as contrast agents for in vivo X-ray computed tomography imaging. J A Chem Soc, 2013, 135: 13620-13623
[46]
28 deKrafft K E, Xie Z, Cao G, et al. Iodinated nanoscale coordination polymers as potential contrast agents for computed tomography. Angew Chem Int Ed, 2009, 48: 9901-9904
[47]
29 Hainfeld J F, Slatkin D N, Focella T M, et al. Gold nanoparticles: A new X-ray contrast agent. Br J Radiol, 2006, 79: 248-253
[48]
30 Shukla R, Bansal V, Chaudhary M, et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir, 2005, 21: 10644-10654
[49]
31 Au J T, Craig G, Longo V, et al. Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. Am J Roentgenol, 2013, 200: 1347-1351
[50]
32 Dreaden E C, Alkilany A M, Huang X, et al. The golden age: Gold nanoparticles for biomedicine. Chem Soc Rev, 2012, 41: 2740-2779
[51]
33 Yusa N, Jiang M, Mizuno K, et al. Numerical evaluation of the effectiveness of colloidal gold as a contrast agent. Radiol Phys Technol, 2009, 2: 33-39
[52]
34 Xu C, Tung G A, Sun S. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater, 2008, 20: 4167-4169
[53]
35 Kim D, Park S, Lee J H, et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc, 2007, 129: 7661-7665
[54]
36 Cormode D P, Skajaa T, van Schooneveld M M, et al. Nanocrystal core high-density lipoproteins: A multimodality contrast agent platform. Nano Lett, 2008, 8: 3715-3723
[55]
37 Guo R, Wang H, Peng C, et al. X-ray attenuation property of dendrimer-entrapped gold nanoparticles. J Phys Chem C, 2009, 114: 50-56
[56]
38 Peng C, Zheng L, Chen Q, et al. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials, 2012, 33: 1107-1119
[57]
39 Peng C, Wang H, Guo R, et al. Acetylation of dendrimer-entrapped gold nanoparticles: Synthesis, stability, and X-ray attenuation properties. J Appl Polym Sci, 2011, 119: 1673-1682
[58]
40 Wang H, Zheng L, Peng C, et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials, 2011, 32: 2979-2988
[59]
41 Guo R, Wang H, Peng C, et al. Enhanced X-ray attenuation property of dendrimer-entrapped gold nanoparticles complexed with diatrizoic acid. J Mater Chem, 2011, 21: 5120-5127
[60]
42 Zhou B, Zheng L, Peng C, et al. Synthesis and characterization of PEGylated polyethylenimine-entrapped gold nanoparticles for blood pool and tumor CT imaging. ACS Appl Mater Inter, 2014, 6: 17190-17199
[61]
43 Hainfeld J F, O'connor M J, Dilmanian F A, et al. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br J Radiol, 2011, 84: 526-533
[62]
44 Wang H, Zheng L, Peng C, et al. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials, 2013, 34: 470-480
[63]
45 Liu H, Xu Y, Wen S, et al. Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles. Chem Eur J, 2013, 19: 6409-6416
[64]
46 Popovtzer R, Agrawal A, Kotov N A, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett, 2008, 8: 4593-4596
[65]
47 Eck W, Nicholson A I, Zentgraf H, et al. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett, 2010, 10: 2318-2322
[66]
48 Sun I C, Eun D K, Na J H, et al. Heparin-coated gold nanoparticles for liver-specific CT imaging. Chem Eur J, 2009, 15: 13341-13347
[67]
49 Liu H, Wang H, Xu Y, et al. Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of Human Hepatocellular Carcinoma. ACS Appl Mater Inter, 2014, 6: 6944-6953
[68]
50 Feng G, Kong B, Xing J, et al. Enhancing multimodality functional and molecular imaging using glucose-coated gold nanoparticles. Clin Radiol, 2014, 69: 1105-1111
[69]
51 Dorsey J F, Sun L, Joh D Y, et al. Gold nanoparticles in radiation research: Potential applications for imaging and radiosensitization. Transl Cancer Res, 2013, 2: 280-291
[70]
52 Alric C, Taleb J, Duc G L, et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc, 2008, 130: 5908-5915
[71]
53 Park J, Kim H K, Kim J H, et al. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg Med Chem Lett, 2010, 20: 2287-2291
[72]
54 Li K, Wen S, Larson A C, et al. Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer. Int J Nanomed, 2013, 8: 2589-2600
[73]
55 Chen Q, Li K, Wen S, et al. Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials, 2013, 34: 5200-5209
[74]
56 Wen S, Li K, Cai H, et al. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials, 2013, 34: 1570-1580
[75]
57 Guo C, Jin Y, Dai Z. Multifunctional ultrasound contrast agents for imaging guided photothermal therapy. Bioconjug Chem, 2014, 25: 840-854
[76]
58 Jin Y, Wang J, Ke H, et al. Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials, 2013, 34: 4794-4802
[77]
59 Ke H, Wang J, Tong S, et al. Gold nanoshelled liquid perfluorocarbon magnetic nanocapsules: A nanotheranostic platform for bimodal ultrasound/magnetic resonance imaging guided photothermal tumor ablation. Theranostics, 2014, 4: 12-23
[78]
60 Ke H, Yue X, Wang J, et al. Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancer. Small, 2014, 10: 1220-1227
[79]
61 Sun I C, Eun D K, Koo H, et al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew Chem Int Ed, 2011, 50: 9348-9351
[80]
62 van Schooneveld M M, Cormode D P, Koole R, et al. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media Mol Imaging, 2010, 5: 231-236
[81]
63 Jing L, Liang X, Deng Z, et al. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials, 2014, 35: 5814-5821
[82]
64 Zhu J, Zheng L, Wen S, et al. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials, 2014, 35: 7635-7646
[83]
65 Kim D, Jeong Y Y, Jon S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano, 2010, 4: 3689-3696
[84]
66 Huang X, El-Sayed I H, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc, 2006, 128: 2115-2120
[85]
67 Xiao Y, Hong H, Matson V Z, et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics, 2012, 2: 757-758
[86]
68 Huang P, Bao L, Zhang C, et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials, 2011, 32: 9796-9809
[87]
69 Kuo W S, Chang C N, Chang Y T, et al. Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angew Chem Int Ed, 2010, 49: 2711-2715
[88]
70 Black J. Biologic performance of tantalum. Clin Mater, 1994, 16: 167-173
[89]
71 Matsuno H, Yokoyama A, Watari F, et al. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials, 2001, 22: 1253-1262
[90]
72 Chen J Y, Leng Y X, Tian X B, et al. Antithrombogenic investigation of surface energy and optical bandgap and hemocompatibility mechanism of Ti(Ta+5)O2 thin films. Biomaterials, 2002, 23: 2545-2552
[91]
73 Findlay D M, Welldon K, Atkins G J, et al. The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials, 2004, 25: 2215-2227
[92]
74 Bonitatibus Jr P J. Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent. Chem Commun, 2010, 46: 8956-8958
[93]
75 Oh M H, Lee N, Kim H, et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc, 2011, 133: 5508-5515
[94]
76 Lee N, Cho H R, Oh M H, et al. Multifunctional Fe3O4/TaOx core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J Am Chem Soc, 2012, 134: 10309-10312
[95]
77 Zha Z, Yue X, Ren Q, et al. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater, 2013, 25: 777-782
[96]
78 Jin Y, Li Y, Ma X, et al. Encapsulating tantalum oxide into polypyrrole nanoparticles for X-ray CT/photoacoustic bimodal imaging-guided photothermal ablation of cancer. Biomaterials, 2014, 35: 5795-5804
[97]
79 Zha Z, Deng Z, Li Y, et al. Biocompatible polypyrrole nanoparticles as a novel organic photoacoustic contrast agent for deep tissue imaging. Nanoscale, 2013, 5: 4462-4467
[98]
80 Esteban J M, Alonso A, Cervera V, et al. One-molar gadolinium chelate (gadobutrol) as a contrast agent for CT angiography of the thoracic and abdominal aorta. Eur Radiol, 2007, 17: 2394-2400
[99]
81 Carrascosa P, Capu？ay C, Bettinotti M, et al. Feasibility of gadolinium-diethylene triamine pentaacetic acid enhanced multidetector computed tomography for the evaluation of coronary artery disease. J Cardiovasc Comput Tomogr, 2007, 1: 86-94
[100]
82 Zhang L J, Wang Z J, Lu L, et al. Feasibility of gadolinium-enhanced dual energy CT pulmonary angiography: A pilot study in rabbits. Int J Cardiovasc Imaging, 2011, 27: 1069-1080
[101]
83 Liu Y, Liu J, Ai K, et al. Recent advances in ytterbium-based contrast agents for in vivo X-ray computed tomography imaging: Promises and prospects. Contrast Media Mol Imaging, 2014, 9: 26-36
